Policy & Economic Research

Economic Evidence to Support Vaccine Use

The Policy & Economic Research function was established in 2009 with support from the Swedish government in order to strengthen IVI’s work in vaccine introduction. Today, our Policy & Economic Research (PER) team focuses on promoting the use of evidence-based analyses for the introduction of cholera, typhoid and dengue vaccines.

They synthesize evidence, conduct health economics studies, and develop transmission models to help with forecasting and estimations of vaccination impact and costing. They also disseminate evidence to national- and global-level policymakers and donors to support deliberations on vaccine introduction.

Publications produced by PER include a global investment case for oral cholera vaccines and an country-specific investment case for oral cholera vaccines (Bangladesh).